Paraneoplastic hyperexcitability syndrome with continuous muscle fibre activity (Q84061): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A síndrome de hiperexcitabilidade autoimune com atividade contínua da fibra muscular (CMFA), é uma síndrome neuromuscular rara caracterizada por fraqueza muscular, frequentemente miocimia, CMFA, às vezes uma cãibra e síndrome fasciculação e características autonômicas. Parestesia e hiperidrose também são comuns. Também os sintomas do SNC podem estar associados à síndrome de Morvan. Pode aparecer tanto como uma doença autoimune quanto paraneoplásica. Existe uma associação com o timoma._x000D_ _x000D_ A doença é suavizada por anticorpos mediados em particular com anticorpos do canal de potássio (VGKC) e o CASPR2 e menos subtipo LGII._x000D_ _x000D_ Ele responde à terapia sintomática e terapias imunológicas. | |||||||||||||||
| description / en | description / en | ||||||||||||||
The autoimmune hyperexcitability syndrome with CMFA, is a rare neuromuscular syndrome characterised by muscle weakness, often myokymia, CMFA, at times a cramp and fasciculation syndrome and autonomic features. Paraesthesia and hyperhydrosis are also common. Also CNS symptoms can be associated in Morvan`s syndrome. It can appear both as an autoimmune- and a paraneoplastic disease. An association with thymoma exists. The disease is soften antibody mediated in particular with potassium channel antibodies ( VGKC) and the CASPR2 and less LGII subtype. It responds to symptomatic therapy and immune therapies. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1599858362 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1599858362 | |||||||||||||||
| Property / CURIE: CID11:ID_1599858362 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1599858362 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1599858362 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 09:25, 15 August 2026
The autoimmune hyperexcitability syndrome with CMFA, is a rare neuromuscular syndrome characterised by muscle weakness, often myokymia, CMFA, at times a cramp and fasciculation syndrome and autonomic features. Paraesthesia and hyperhydrosis are also common. Also CNS symptoms can be associated in Morvan`s syndrome. It can appear both as an autoimmune- and a paraneoplastic disease. An association with thymoma exists. The disease is soften antibody mediated in particular with potassium channel antibodies ( VGKC) and the CASPR2 and less LGII subtype. It responds to symptomatic therapy and immune therapies.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1599858362 |
||
| English | Paraneoplastic hyperexcitability syndrome with continuous muscle fibre activity |
The autoimmune hyperexcitability syndrome with CMFA, is a rare neuromuscular syndrome characterised by muscle weakness, often myokymia, CMFA, at times a cramp and fasciculation syndrome and autonomic features. Paraesthesia and hyperhydrosis are also common. Also CNS symptoms can be associated in Morvan`s syndrome. It can appear both as an autoimmune- and a paraneoplastic disease. An association with thymoma exists. The disease is soften antibody mediated in particular with potassium channel antibodies ( VGKC) and the CASPR2 and less LGII subtype. It responds to symptomatic therapy and immune therapies. |
Statements
CID11:ID_1599858362
0 references
dki-india-ID_1599858362
0 references
Concluído
0 references
13 August 2026
0 references
